Prestige Consumer Healthcare Inc.
PBHNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for PBH. That does not mean none is planned.
Get an email about PBH's next catalysts
Track Prestige Consumer Healthcare (PBH) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Prestige Consumer Healthcare Inc. (formerly Prestige Brands, Inc.) is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York: 2 and operates a manufacturing facility in Lynchburg, Virginia.: 9
WebsiteFrequently asked questions
What is in Prestige Consumer Healthcare Inc.'s drug pipeline?β
CatalystAlert tracks 3 drug candidates in Prestige Consumer Healthcare Inc.'s (PBH) pipeline across Phase 3, Phase 2. Its lead program is HD201 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Prestige Consumer Healthcare Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Prestige Consumer Healthcare Inc. (PBH) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track PBH biotech catalysts?β
Add PBH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Prestige Consumer Healthcare Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
